Delivery Order SPE2DB24D1034-SPE2DB25FWAG5

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,365.37 firm fixed-price delivery order contract is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,148.46 firm fixed-price delivery order is for the supply of UBRELVY 50 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM0B1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,715.83 Firm Fixed Price Delivery Order contract covers the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. This award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a range...
This federal contract award, valued at $1,194.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has an ultimate completion date of August 30, 2023 and utilizes a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,236.54 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of August 27, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,634.72, is a delivery order contract for the supply of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,898.48 firm-fixed-price delivery order is for the provision of UBRELVY 100 MG TABLET UD 10S, a prescription medication. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,127.76 firm fixed price delivery order covers the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product, with a period of performance through January 24, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,704.94 firm fixed-price delivery order is for the supply of UBRELVY 50 MG TABLET UD 10S, a prescription medication. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,367.98 firm fixed-price delivery order is for the supply of UBRELVY 100 MG TABLET UD 16S, a pharmaceutical product. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FWAG5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,315.12 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of the pharmaceutical product UBRELVY 100 MG TABLET UD 16S to support federal medical programs. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 IDC with DLA Troop Support Medical to provide a comprehensive range of medical commodities including specialty medications, generic drugs, vaccines, and medical supplies. This contract has no set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 5/7/25, 10:04 AM